By binding to NKG2D receptor, soluble MICA/B molecules may block the activation of effector lymph cells by MICA/B, thereby facilitate the escape of tumor or infected cells from immunosurveillance[1,2,24-30]. The gene discussed is MICA; the disease is neoplasm.